Leerink Swann Maintains an 'Outperform' on NuVasive (NUVA); 2012 Guidance Looking More and More Conservative

Article Stock Quotes (1) Comments (0)

Leerink Swann maintains an 'Outperform' on NuVasive (NASDAQ: NUVA) price target of $28.00 (from $22.00).

Analyst, Richard Newitter, said, "Our recent MEDACorp spine physician feedback points to stabilizing industry spine volume trends and leaves us incrementally
more positive on NUVA's: (1) above-average sales growth prospects, and (2) potential to exceed 2012 sales guidance as well as our/Street expectations."

For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.

Shares of NuVasive closed at $22.89 yesterday, with a 52 week range of $11.02-$34.82.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
• Goldman Sachs Downgrades Thoratec (THOR) to Neutral
• Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?